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A B S T R A C T
Background: Eating disorders are serious conditions associated with an impaired health-related quality of life
and increased healthcare utilization and costs. Despite the existence of evidence-based treatments, access to
treatment is often delayed due to insufficient health care resources. Internet-based self-help interventions may
have the potential to successfully bridge waiting time for face-to-face outpatient treatment and, thus, contribute
to overcoming treatment gaps. However, little is known about the feasibility of implementing such interventions
into routine healthcare. The aim of this study is to analyze the effects and feasibility of an Internet-based self-
help intervention (everyBody Plus) specifically designed for patients with Bulimia Nervosa, Binge Eating
Disorder and other specified feeding and eating disorders (OSFED) on a waiting list for outpatient face-to-face
treatment. The aim of this paper is to describe the study protocol.
Methods: A multi-country randomized controlled trial will be conducted in Germany and the UK. N=275 fe-
male patients awaiting outpatient treatment will be randomly allocated either to the guided online self-help
intervention “everyBody Plus” or a waitlist control group condition without access to the intervention.
everyBody Plus comprises eight weekly sessions that cover topics related to eating and exercise patterns, coping
with negative emotions and stress as well as improving body image. Participants will receive weekly in-
dividualized feedback based on their self-monitoring and journal entries. Assessments will take place at baseline,
post-intervention as well as at 6- and 12-months follow up. In addition, all participants will be asked to monitor
core eating disorder symptoms weekly to provide data on the primary outcome. The primary outcome will be
number of weeks after randomization until a patient achieves a clinically relevant improvement in core
symptoms (BMI, binge eating, compensatory behaviors) for the first time. Secondary outcomes include frequency
of core symptoms and eating disorder related attitudes and behaviors, as well as associated psychopathology.
Additional secondary outcomes will be the participating therapists' confidence in treating eating disorders as
well as perceived benefits of everyBody Plus for patients.
Discussion: To the best of our knowledge, this is the first randomized controlled trial examining the effects of
Internet-based self-help for outpatients with eating disorders awaiting face-to-face outpatient treatment. If
proven to be effective and successfully implemented, Internet-based self-help programs might be used as a first
step of treatment within a stepped-care approach, thus reducing burden and cost for both patients and health
care providers.
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1. Introduction
Patients with eating disorders (EDs) have significantly impaired
health-related quality of life and EDs are associated with increased
healthcare utilization and healthcare costs (Ágh et al., 2015; Agras,
2001). The impairment is particularly high in patients with binge
eating/purging behavior (DeJong et al., 2013).
Systematic reviews and treatment guidelines have repeatedly re-
commended cognitive-behavior therapy (CBT) as the first choice of
treatment for Bulimia Nervosa (BN) and Binge Eating Disorder (BED)
(Mitchell et al., 2007; National Institute for Health and Care Excellence
(NICE), 2017; Vocks et al., 2010; Wilson and Shafran, 2005). However,
access to treatment is often limited or delayed. Apart from barriers in
the help-seeking process on the side of the patient [e.g., fear of stig-
matization, poor treatment motivation or lack of knowledge regarding
the ED (Becker et al., 2010; Evans et al., 2011)], mental health care
delivery in many countries is characterized by a gap between demand
and availability of evidence-based treatments (Knapp et al., 2007; Kohn
et al., 2004). Moreover, even when people with mental health disorders
(e.g., eating disorders) decide to seek professional help, they often do
not receive prompt support due to limited face-to-face treatment ca-
pacities and long waiting periods. In Germany, for example, more than
every fourth adult is affected by one or more mental health disorders
(Jacobi et al., 2014); the number of licensed psychotherapists however,
is not sufficient to meet this demand (BPtK, 2011). A report from the
German Psychotherapists' Association (“Bundespsychother-
apeutenkammer”) showed that people seeking outpatient treatment
have to face on average a three-month waiting period until an initial
meeting can be scheduled (BPtK, 2011) and even more time elapses
until the first treatment session takes place.
In the UK, the picture is similar. It is estimated that only a quarter of
people with a mental health disorder receive any treatment at all (The
Centre for Economic Performance's Mental Health Policy Group, 2012).
Of these, only 10% receive evidence-based psychological therapies.
Over half of the people affected by mental health problems wait more
than three months until treatment is started – and one tenth has to wait
for more than a year (Mind, 2013). The UK mental health charity Mind
recommends that waiting time should not exceed a maximum of four
weeks (Mind, 2013) as shorter waiting periods are associated with
greater treatment satisfaction (Mind, 2010).
For patients with eating disorders, barriers to treatment are parti-
cularly high as some therapists decline treating these patients (Burket
and Schramm, 1995). The rather poor long-term outcome (Steinhausen
and Weber, 2009), the associated physical and comorbid conditions and
patients` ambivalence towards treatment can result in therapists feeling
poorly equipped to take on these patients and discourage them from
providing treatment at all (Burket and Schramm, 1995). Evidence from
epidemiological studies shows that only a small proportion of patients
(6%) suffering from Bulimia Nervosa receive psychological treatment
(Hoek, 2006). Given the seriousness of the disorders and the associated
burden and costs (Ágh et al., 2015; Agras, 2001), providing people with
EDs with adequate interventions as early as possible is of crucial im-
portance.
However, some researchers suggest that limited resources will al-
ways be a problem in most health care systems, even if the number of
trained specialists is scaled up (Fairburn and Patel, 2014). Accordingly,
alternative ways of providing psychological treatments have to be de-
signed and implemented to lower current barriers to care. Self-help
interventions may help to facilitate immediate access to metal health
care, thus bridging the treatment gap for patients with BN and BED
(Beintner et al., 2014). Several studies have shown that a considerable
proportion of patients (9–64%, median 30%) with BN and BED achieve
abstinence from binge eating after 8–12weeks only by participating in
a CBT-based (online or offline) self-help program (Beintner et al.,
2014), with guided self-help programs showing better effects than un-
guided programs (Beintner et al., 2014). As part of a stepped care
approach, current treatment guidelines for BN and BED, recommend
participating in a self-help program as a first step of treatment (National
Institute for Health and Care Excellence (NICE), 2017). Using a CBT-
based self-help program as the first step in treatment of BN was more
effective in terms of reducing ED-related psychopathology (frequency
of binge eating and compensatory behaviors) (Mitchell et al., 2011) and
more cost-effective (Crow et al., 2013) in comparison with conventional
CBT as a first step in treatment. Hence, delivering self-help interven-
tions at an early stage at a first step of treatment may also be a pro-
mising strategy to manage limited resources for outpatient treatment
(Crow et al., 2013).
In recent years, self-help interventions have increasingly been of-
fered online. To date, the effects of Internet-based interventions as a
stand-alone treatment for BN and BED have only been evaluated in a
small number of trials (Aardoom et al., 2016a; Carrard et al., 2011a,c;
Ruwaard et al., 2013; Sanchez-Ortiz et al., 2011; ter Huurne et al.,
2015) and considered in recent systematic reviews with mainly pro-
mising results (Aardoom et al., 2013, 2016b; Bauer and Moessner,
2013; Dolemeyer et al., 2013; Le et al., 2017; Loucas et al., 2014;
Melioli et al., 2016; Schlegl et al., 2015). In general, compared with
waiting list controls, Internet-based interventions proved to be more
effective in reducing global ED pathology (including the frequency of
binge eating and compensatory behaviors) and were associated with a
greater improvement of ED related quality of life (Aardoom et al.,
2013). Online self-help has also been shown to contribute to motivation
for change (d= 0,52–0,87), even if the focus is not mainly on ED
symptoms (Hötzel et al., 2014). Nevertheless, evidence from rando-
mized controlled trials on the impact of Internet-based self-help inter-
ventions in routine care settings (e.g., outpatient or inpatient treatment
centers) is limited, especially when used to bridge waiting time for
psychotherapy.
However, using online self-help interventions to bridge waiting time
for outpatient face-to-face psychotherapy could have several ad-
vantages: Patients can receive some basic psychoeducational informa-
tion on EDs online, which saves time that can be used to address other
problems (e.g., interpersonal, emotional problems, comorbidities)
during subsequent face-to-face treatment. Participation in an online
guided self-help program instead of simply waiting for face-to-face
treatment could also facilitate the motivation for change and keep this
motivation active during the waiting period. Overall, participation in
an online self-help intervention during the waiting period may have the
potential to reduce ED symptoms (or to prevent ED symptom progres-
sion) and to better prepare the patient for subsequent treatment. This
could – at best – result in a more rapid improvement of ED core
symptoms and fewer face-to-face sessions subsequently needed or even
make a subsequent face-to-face treatment unnecessary, thus, also pro-
viding a potentially more cost-effective alternative to face-to-face
treatment.
In the field of eating disorders, to our knowledge, no trial has been
conducted in which an online self-help intervention was offered with
the aim of bridging waiting times. Preliminary evidence on the effects
of such interventions comes from non-randomized controlled trials.
Carrard et al. (2011b) offered a guided self-help online BED program to
obese patients with BED on a waiting list for a weight loss treatment
program. The study was not specifically designed to bridge waiting
time, but participants were recruited from an existing waiting list and
the intervention was offered during their 6-month waiting period.
Around half of the patients (55%) invited to take part in the online
program chose to participate instead of waiting. Their data were com-
pared with data from patients who waited for their treatment without
receiving the opportunity to participate in the online program. At post-
intervention, a higher percentage of patients in the self-help condition
reported abstinence from binge eating compared with patients in the
control condition (45 vs. 15%; N=42). Positive effects were also found
for disordered eating attitudes (e.g., EDE-Q weight and shape concerns)
and quality of life (Carrard et al., 2011b). These effects were
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maintained until 6 months follow-up, after all BED patients had taken
part in the weight loss treatment program they had registered for.
In addition, only two randomized controlled trials have been pub-
lished for other mental health disorders, i.e., depression and anxiety
disorders (Kenter et al., 2016; Kok et al., 2014). In the first study, an
Internet-based problem solving treatment produced comparable out-
comes in patients with major depression to the use of an unguided self-
help book while waiting for treatment (Kenter et al., 2016). In the
second study, participation in an Internet-based program for phobias
was associated with a significantly greater reduction in phobic and
depressive symptoms at 5 weeks posttest, compared to a waiting list
control group receiving a self-help book only (Kok et al., 2014).
Taken together, there is limited evidence on the use and effects of
Internet-based interventions to bridge waiting time for face-to-face
treatment for mental disorders, although results of the few available
studies show some promise. Although effective as stand-alone inter-
ventions, online self-help interventions may have different effects when
being offered to outpatients awaiting face-to-face treatment. The aim of
our study, therefore, is to assess the effects of an Internet-based inter-
vention designed to bridge waiting time for outpatient face-to-face
treatment for BN, BED and other specified feeding and eating disorders
(OSFED). The current study is the first study to offer an online inter-
vention for patients with an ED during the waiting period for outpatient
treatment, and evaluate its effects compared with the effects of out-
patient treatment only. As patients will be enrolled in regular face-to-
face treatment afterwards, it is unclear how this might influence their
motivation to use the program and adhere to it.
2. Materials and methods
2.1. Objectives and hypotheses
Self-help interventions could have the potential to bridge the
treatment gap for BN and BED and could represent a first step in a
stepped-care approach. However, they have hardly been implemented
in routine mental health care settings (e.g., private practices, outpatient
centers). To address this shortcoming, we aim to evaluate the effects of
a guided Internet-based self-help program (everyBody Plus) for female
patients with BN, BED and OSFED awaiting outpatient treatment. We
expect the included everyBody Plus intervention to be associated with
both a more rapid reduction of core eating disorder symptoms and
higher abstinence rates compared with the control condition who re-
main on the waiting list and do not receive the intervention.
2.2. Participants and recruitment
We will include women aged 18 and above who seek outpatient
face-to-face treatment for Bulimia Nervosa (BN), Binge Eating Disorder
(BED) or other specified feeding and eating disorders (OSFED) ac-
cording to DSM5 (American Psychiatric Association, 2013). Although it
is increasingly recognized that men, too, develop eating disorders, in-
terventions for men need to consider the rather different symptom
patterns and manifestations of ED in males (Calzo et al., 2016). Due to
the time and financial constraints of this study, this was not possible
here. An adaption of the intervention for men may be created in the
future. Eligible patients need to have access to the internet and give
informed consent to participation in the study.
We will exclude (i) patients with a BMI < 18.5 kg/m2, (ii) patients
in need for inpatient eating disorder treatment due to the severity of the
disorder, (iii) patients with significant psychiatric comorbidity needing
treatment in its own right (e.g., substance dependence, major psy-
chiatric disorders or acutely suicidal tendency), (iv) patients on anti-
depressant medication who have not been on a stable dose for at least
four weeks. Also, patients will be excluded if they are not eligible for
treatment coverage by health insurances or the NHS due to low
symptom severity, based on the judgement of the cooperating therapist
or researcher of this study.
2.2.1. Recruitment in Germany
In Germany, we will recruit participants via cooperating psy-
chotherapists in private practices and outpatient treatment centers as
well as psychotherapy training institutions. Psychotherapists (clinical
psychologists, psychiatrists, GPs with additional qualification in psy-
chosomatics) are eligible for cooperation if they are licensed to conduct
Cognitive Behavioral Therapy (CBT) or Psychodynamic Therapy (PDT)
in Germany or are in supervised training to be licensed, keep a waiting
list for their practice or institution (i.e., see patients for one diagnostic
session and cue them up for the next upcoming timeslot) and are willing
to treat women with eating disorders. Cooperating therapists and out-
patient treatment centers are recruited via mailings, phone calls and
(print and e-mail) announcements through professional organizations
as well as an advertisement in the journal of the German clinical psy-
chologists' association (Bundespsychotherapeutenkammer), which is
received by every licensed clinical psychologist in Germany.
In addition, we will implement a second recruitment strategy by
directly approaching women with BN, BED or OSFED without the in-
volvement of a licensed psychotherapist. Within this recruitment pro-
cedure, interested women awaiting outpatient treatment are able to
refer themselves to the study. Potential participants will be informed
about the opportunity to take part in the study via flyer and other in-
formation materials in counselling centers, self-help groups, (online)
help-seeking forums and websites dealing with eating disorders. To be
considered for participation, it is necessary that a certified physician or
psychotherapist confirm their eating disorder symptomatology and
other study-relevant symptoms (i.e., inclusion and exclusion criteria).
Following this confirmation, the study team will decide if the woman is
eligible to participate in the study.
2.2.2. Recruitment in the UK
In the UK, we will recruit participants from multiple sources. The
South London and Maudsley NHS Foundation Trust is a confirmed re-
cruitment site. This hospital trust has a large catchment area and offers
healthcare services to approximately 2 million people. Additional hos-
pital trusts can view the UK study on the National Institute for Health
Research Clinical Research Network (NIHR CRN) Portfolio database
and apply to become recruitment sites. Additional participants will be
recruited via the KCL website and the KCL staff and student medical
center. Advertising through the national ED charity Beat will allow
generate UK-wide interest in the study. Furthermore, the study will be
advertised in university email circulars sent by administrators to the
student population of UK universities.
2.3. Study design and randomization
This study is a pragmatic multi-country, multicenter, randomized
controlled trial with 2 parallel conditions (everyBody Plus vs. waiting
list control condition), conducted in Germany and the UK. Core ED
symptoms (BMI, binge eating, compensatory behaviors) will be assessed
weekly during a 52week period. In addition, secondary outcomes will
be assessed at pre- and post-intervention as well as 6- and 12-months-
follow-up (see Fig. 1).
At the end of their initial diagnostic session, patients who are put on
a waiting list and cannot start treatment immediately will receive
written information about the study along with an access code for the
program website that identifies the therapist who referred them. In the
case of self-referred participants, the access code will be given directly
to participants by the study team. Entering the access code is obligatory
for the registration in the online program. The patients will subse-
quently receive detailed written information about the study on the
program website and be able to give informed consent. Participants are
reminded that that the online program is offered specifically to women
with BN, BED or OSFED who may be on a waiting list for face-to-face
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outpatient therapy and that participation in the program is not meant as
substitute for psychotherapy but could be used to bridge waiting time
with beneficial effect. After the sign-up process and completion of a
baseline assessment, patients will be randomly allocated to either
everyBody Plus or the waiting list control condition on the basis of a
computer-generated randomized number list. After randomization,
women in the everyBody Plus group will receive access to the online
self-help intervention in addition to being prompted to monitor their
symptoms weekly, while women in the waiting list condition will only
be prompted to monitor their symptoms weekly. Women will take up
regular outpatient psychotherapy sessions whenever a timeslot be-
comes available. Weekly symptom monitoring continues until
12 months (52weeks) past randomization. Secondary outcomes will be
assessed at post-intervention and FU assessments (6 and 12months past
randomization). In addition, cooperating therapists in Germany will be
asked to provide information on the number and dates of sessions
conducted with participating patients and an evaluation of current ED
specific symptomatology quarterly (once the participant starts regular
outpatient treatment).
In the UK, a minority of participants will be recruited through ad-
vertisements and word-of-mouth, and thus will not be screened for the
study by their NHS health care provider. The eligibility of these parti-
cipants will be assessed over the phone by a trained researcher of the
KCL team, under the supervision of a psychiatrist, and in accordance
with the specific inclusion and exclusion study criteria. For participants
who are referred to the study through an NHS service provider data on
treatment attendance will be obtained from the hospital trust's elec-
tronic patient monitoring system. Participants recruited outside of NHS
sites will be asked to provide information on attending face-to-face
treatment through the weekly symptom diary and the post-intervention
and follow-up assessments.
Patients can collect points for each timely completed weekly
symptom checklist and baseline/post-intervention/FU-assessment.
They can redeem these points for money or vouchers after 12 months
(after FU12 assessment). Cooperating therapists in Germany will re-
ceive an expense allowance for the additional effort of providing in-
formation on treatment dose and current symptomatology (25€ per
quarter per trial patient in treatment).
The trial is registered at http://www.isrctn.org, number
ISRCTN12608780. Ethics approval has been obtained by the ethics
committee of TU Dresden (EK 84032016) and both King's College
London and the NHS (North West – Greater Manchester East Research
Ethics Committee reference number 16 /NW/0888). The trial will be
conducted in compliance with the protocol, the Declaration of Helsinki
and good clinical practice. All relevant EU legislation and international
texts on privacy will be observed and respected.
2.4. Intervention
everyBody Plus is an eight-week online self-help program based on
ED specific cognitive behavioral therapy for women who binge eat. The
main focus is on reducing and/or preventing binge eating by im-
plementing alterative behavioral strategies into daily life. In line with
this, everyBody Plus aims to do the following: (i) to communicate a
positive body image, (ii) to support the development and maintenance
of balanced eating, (iii) to teach alternative behavioral strategies in
situations where unhelpful eating behaviors occur, (iv) to enhance self-
confidence independently of weight and body shape.
The program consists of eight weekly sessions and includes reading
assignments, a weekly symptom checklist assessing the number of
binges and compensatory behaviors per week, a personal journal and
behavioral exercises. Topics covered are the development and main-
tenance of eating disorders, balanced eating and exercise patterns,
dealing with “forbidden foods” and binge eating/purging, improving
body image, coping with stress and negative emotions, perfectionism
and self-esteem. everyBody Plus was designed to target psychological
conditions of BN and BED (binge eating), without directly addressing
weight loss and weight management. Patients will receive weekly
personal feedback based on their self-monitoring and journal entries.
The program is supplemented by a moderated asynchronous dis-
cussion board to exchange experiences and thoughts with other pa-
tients. Trained clinical psychologists or certified psychologists with a
master's degree supervised by a psychotherapist licensed to conduct
CBT will provide personal feedback and moderate the online discussion
board. everyBody Plus program moderators attended a training work-
shop where they learned about the specific philosophy of the inter-
vention and received detailed instructions on intervention delivery. The
Internet-based and therefore site-independent intervention is guided by
staff at TU Dresden (German version) and KCL (English version).
Cooperating therapists in Germany will not be involved in the self-help
intervention. Nominated therapists in participating eating disorder
units in the UK will be trained in providing online support to partici-
pants at a half-day workshop hosted by study researchers. At the end of
each session, participants will be asked to give brief feedback on how
helpful they found the session.
An earlier version of the program [StudentBodies+ (German ver-
sion) and StudentBodies-Eating Disorders (English version)] has pre-
viously been shown to be effective in reducing ED symptoms in RCTs of
young women with subthreshold eating disorders (Jacobi et al., 2012;
Saekow et al., 2015). Within the present RCT, the program is used in
women with full syndrome eating disorders (BN, BED, OSFED) awaiting
outpatient face-to-face treatment. For this purpose, the StudentBodies
Plus program was revised and adapted to the specific target group of
women with eating disorders with binge eating behavior and migrated
into a new online platform. Mainly, we updated the layout of the pro-
gram, replaced long text passages by explanatory videos and included
Fig. 1. Study design.
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written and audio testimonials of fictitious participants. Although it is
expected that many participants will proceed to regular outpatient
therapy afterwards, we emphasize the benefits of working with every-
Body Plus, to increase the participants' motivation to adhere to and
complete the intervention. Also, we implemented a weekly symptom
checklist to allow monitoring of ED core symptoms and provision of the
primary outcome. The name of the program was changed to everyBody
Plus in order to show that the program is applicable to women of all
ages and not just students. A responsive web-design allows patients to
access the intervention though the Internet, a mobile phone or a tablet.
2.4.1. Control condition
Patients allocated to the waiting list control condition will only be
prompted to complete the weekly self-monitoring of core ED symptoms.
They will neither receive access to the program nor receive feedback on
their entries in the symptom checklist. In case of problems with using
the platform, participants will receive technical support from the
everyBody Plus team. The benefits of monitoring eating disorder
symptoms (systematically monitoring eating habits, recognizing pro-
gress and changes, being aware of periods with unhelpful eating be-
haviors) are emphasized, to keep participants in the control group en-
gaged with the study.
2.5. Assessment and data management
Assessments will be conducted before randomization (baseline, T1),
at the end of the intervention (8 weeks past randomization, T2) as well
as at 6- (T3) and 12-month-follow up (T4). A short intermediate as-
sessment will take place 4 weeks past randomization. All questionnaires
are given online. Participants will benefit from being awarded points
for each completed assessment, which they are able to redeem for cash
or a voucher upon completion of the study.
Table 1 gives an overview of instruments that will be used at each of
the four main assessment points. Additional measures addressing po-
tential moderator and mediator variables are included (see Secondary
outcomes section).
All study data will be collected on the Minddistrict platform. Data
management and monitoring will be provided by Westfälische
Wilhelms-Universität Münster for the whole ICare consortium in order
to maintain a comparably high quality in the conduct of the ICare re-
search projects. Study data are monitored for completeness, timeliness
and interval validity. The processing of a personal data plan is protected
by appropriate technical and organizational measures. Personal data
will be pseudonymized and any data transfer will be encrypted, e.g. by
SSL secured HTTPS connection. After the end of the trial, data will be
anonymized for further analysis. Only aggregated data will be pre-
sented in any publication resulting from the study.
2.6. Outcomes
2.6.1. Primary outcome
The primary outcome is the number of weeks after randomization
until a patient achieves a clinically relevant improvement in core
symptoms for the first time. Clinically relevant improvement is defined
as abstinence from binge eating and compensatory behaviors and a
BMI > 18.5 kg/m2 over a period of at least four weeks. To assess the
primary outcome, each participant will be asked to monitor the pre-
sence and frequency of eating disorder symptoms (binge eating and
compensatory behaviors) in a weekly symptom checklist. The checklist
contains eight questions assessing the frequency of binge eating and
compensatory behavior. These frequencies are measured as numeric
variables.
2.6.2. Secondary outcomes
Secondary outcomes include standard ED measures as well as
measures assessing associated psychopathology. The Eating Disorder
Examination Questionnaire [EDE-Q (Fairburn and Beglin, 2008; Hilbert
and Tuschen-Caffier, 2006)] will be used to assess ED psychopathology.
Also, frequencies of core ED symptoms (i.e., binge eating, compensatory
behaviors) in the previous month will be assessed. The five-item Weight
Concerns Scale [WCS (Grund, 2003; Killen et al., 1996)] will be used to
assess concerns with weight as associated to body image. Fruit and
vegetable consumption in the last seven days will be assessed by four
questions asking about the intake of fruit, vegetable, smoothies and
juices. To assess whether participants take their meals depending on
physical cues of hunger and satiety, the Intuitive Eating Scale [IES
(Herbert et al., 2013; Tylka, 2006)] will be used. BMI will be calculated
via self-reported weight and height.
As secondary outcome measures of associated psychopathology, we
will use the Patient Health Questionnaire 9 [PHQ-9 (Löwe et al., 2004)]
assessing depression, the Generalized Anxiety Disorder 7 [GAD-7
(Spitzer et al., 2006)] assessing anxiety and the Alcohol Use Disorders
Identification Test-Consumption [AUDIT-C (Bush et al., 1998; Wurst
et al., 2013)] assessing alcohol consumption. For the assessment of
quality of life, we will use the Assessment of Quality of Life-8D [AQoL-
8D (Richardson et al., 2014)]. The Rosenberg Self-Esteem Scale [RSE
(Ferring and Filipp, 1996; Rosenberg, 1965)] will be used to measure
self-esteem. For health-economic analyses, the Client Service Receipt
Inventory [CSRI (Beecham and Knapp, 2001)] will be administered at
each of the four main assessment points. This allows frequency of ser-
vice contacts to be recorded in a manner commensurate with estimating
the costs of treatment.
Within the trial, we will also assess potential moderators and
mediators of adherence and outcome. Potential moderator variables
(e.g., sociodemographic variables, participants' expectations and in-
tention to use the program) will be assessed prior to randomization.
Potential mediator variables (e.g., change in psychopathology,
Table 1
Measures and time points of assessment.
Measures Baseline Post intervention (week 8) FU 6months FU 12months
ED core symptoms Binge eating and compensatory behavior x x x x
EDE-Q Eating disorder psychopathology x x x x
WCS Weight and shape concerns x x x x
IES Intuitive eating tendencies x x x x
PHQ-9 Symptoms of depression x x x x
GAD-7 Symptoms of anxiety x x x x
AUDIT-C Alcohol consumption x x x x
AQoL-8D Quality of life x x x x
RSE Self-esteem x x x x
CSRI Economic evaluation x x x x
EDE-Q Eating Disorder Examination-Questionnaire, WCS Weight Concerns Scale, IES Intuitive Eating Scale, PHQ-9 Patient Health Questionnaire 9, GAD-7 Generalized Anxiety Disorder
7, AUDIT-C Alcohol Use Disorders Identification Test-Consumption, AQoL-8D Assessment of Quality of Life-8D, RSE Rosenberg Self-Esteem Scale, CSRI Client Service Receipt Inventory,
FU Follow up.
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satisfaction with treatment) will be assessed once during the interven-
tion (four weeks post randomization). Also, the therapeutic alliance will
be assessed using the Working Alliance Inventory – short revised [WAI-
SR (Hatcher and Gillaspy, 2006; Wilmers et al., 2008); intervention
group only]. Expectations towards the everyBody Plus intervention will
be assessed at pre- and mid-intervention using the “Stundenbogen für
die Allgemeine und Differentielle Einzel-Psychotherapie” [STEP
(Krampen, 2002); patient version modified for online interventions].
Adherence to the intervention (e.g., the number of completed sessions,
completed diary entries or messages written in the discussion board),
will be tracked automatically through the online intervention platform.
In addition, participating therapists' confidence in treating eating
disorders (self-report on relevant therapeutic skills and emotions while
treating patients with Eating Disorders) will be assessed and therapists'
perceived benefits of everyBody Plus for patients will be measured
using the “Stundenbogen für die Allgemeine und Differentielle Einzel-
Psychotherapie” [STEP (Krampen, 2002); therapist version modified for
online interventions]. NHS therapists in the UK will complete the
English version of the STEP (Krampen, 2002). Also, cooperating
therapists will be asked once per quarter to provide information about
the number of therapy session utilized by the participant.
2.7. Statistical methods
The statistical analysis of the primary and secondary outcomes
follows adopted guidelines, e.g. ICH E9 and will be described in more
detail in a statistical analysis plan (SAP). Before final data analysis, a
blinded data review step will be performed, to inform decisions on the
imputation strategy and selection of potential covariates in multi-
variable model. Overall, the analysis strategy for this trial consists of
four steps: (i) data description, (ii) analysis of the primary hypothesis
including sensitivity analyses, (iii) secondary analyses, and (iv) further
exploratory analyses.
The balancing of participant randomization will be checked by ap-
propriate statistical tests on the baseline variables. Furthermore, the
study collective will be characterized by descriptive statistical methods.
Absolute and relative frequencies will be used for categorical variables,
means, median, standard deviations and inter quartile range will be
used for continuous variables. Additionally, suitable graphics will be
used to display the data, such as histograms, boxplots and bar charts.
Means and medians will be supplemented by 95% confidence intervals
(CI). All measurement time points will be described separately. Also,
descriptive statistics will be provided for both study arms. Assumptions
about the statistical distribution of measured variables will be tested
using appropriate test. Normality will be assessed by histograms, kur-
tosis and the Kolmogorov-Smirnov test.
2.7.1. Primary confirmatory analysis
The primary hypothesis of the trial tests if participants benefit from
the online program compared to a waiting list condition. The effect of
the program is tested using a time-to-event endpoint. For the primary
outcome, time to clinically relevant improvement of ED symptoms, the
two arms everyBody Plus-self-help and waiting list control condition
will be compared using a two-sided log rank test. The primary analysis
will be performed on the full analysis set of patients who provided data
at baseline (ITT principle). The primary analysis will be performed on a
multiple significance level of 5% within a 2-stage adaptive design
planned for this trial. An interim analysis is planned after 39 events
have been observed. The purpose of the interim analysis is mainly to
recalculate the sample size.
The results of the trial will be reported according to the CONSORT
2010 Statement (Eysenbach and Consort-Ehealth Group, 2011; Moher
et al., 2001, 2010).
2.7.2. Sensitivity analyses
After the final analysis, sensitivity analyses on the primary analysis
will be performed using the per-protocol (PP) collective. Furthermore,
we will fit a Cox-proportional model including variables preselected in
the blinded review of the data. Baseline variables that qualify as po-
tential confounders will also be considered for this sensitivity analysis.
Additionally, a stratified analysis by country (Germany, UK) and within
strata (subgroup analysis) will be performed.
2.7.3. Secondary analyses
Analyses of the secondary outcomes at individual time points will be
made by either using Student's t-Test for unpaired data or Mann-
Whitney U test, depending on normal distribution of scores. Categorical
variables will be analyzed using Fisher's Exact Test or Chi-Squared tests.
Additionally, primary and secondary outcomes will be analyzed using
multilevel mixed effect models (MMEM) and multivariable Cox pro-
portional hazard models. Separate MMEM models will be calculated for
each secondary outcome variable. Depending on the distribution of
data, we will choose linear models (for normally distributed data) or
negative binomial models (for left-skewed data). Each model includes
assessment time as a predictor. Further covariates will be entered as
necessary, e.g. baseline characteristics of participants, or variables as-
sociated with dropout, to control for confounding. We will perform a
competing risk analysis of the primary endpoint to assess the effects of
simultaneously occurring events, such as start of face-to-face therapy.
Missing data in secondary analyses will be handled using Full-in-
formation-maximum likelihood estimation. We will consistently use the
nominal significance level of 0.05 (two-tailed).
2.7.4. Moderator and mediator analyses
Moderator and mediator analyses will be conducted within a sepa-
rate work package of the ICare project.
2.7.5. Cost-effectiveness analyses
Cost-effectiveness analyses will be conducted within a separate
work package of the ICare project.
2.8. Sample size calculation
The study was designed with a recruitment phase of 2 years. Each
participant has a fixed follow up duration of 12months, i.e., after the
end of the fixed follow up no further information about a patient's status
will be acquired. We account for this mode of accrual and follow up by
estimating the number of events necessary to show the assumed effect
with at least 80% power and calculate the necessary number of parti-
cipants directly by solving for N under the calculated number of events
and the assumed event rates. Event rates are assumed to follow an
exponential distribution and the dropout rate is assumed to be equal in
both groups. For the purpose of sample size calculation for the planned
time to event analysis, we assumed an expected rate of events (ED
symptom improvement) after 8months of 0.5 in the intervention group
and of 0.3 in the waiting list group, based on published data on ab-
stinence rates after outpatient treatment (e.g. Fairburn et al., 2009). To
detect a 20% difference in event rates between the intervention group
and the waiting list group, a sample size of N= 193 is sufficient. As the
probability of study drop out is estimated to be 30% during a 12month
follow up, a total of N=275 participants have to be randomized
(completed baseline assessment). For the sample size calculation, a 2-
stage adaptive group sequential design was planned according to Wang
and Tsiatis (1987). The purpose of the interim analysis is a sample size
recalculation based on the observed effect within the first stage of the
trial. The sample size of the second stage will be calculated using the
inverse normal method (Lehmacher and Wassmer, 1999) to maintain a
conditional power of 80% in the second stage.
3. Discussion
Patients seeking help for mental health disorders often receive
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access to specialized mental health care only after a significant period
of delay. Internet-based interventions could help bridge the gap be-
tween seeking help and start of treatment.
The number of trials investigating Internet-based self-help for the
treatment of mental disorders including BN, BED and OSFED is still
small but is growing. Existing research has demonstrated that internet-
based self-help can be a promising alternative to traditional cognitive
behavioral therapy in a face-to-face setting (Dolemeyer et al., 2013).
However, most of the evidence is based on trials with samples recruited
from the general population and self-referred participants. Also, effects
of internet-based self-help usually have been investigated as a stand-
alone intervention. However, to date, little is known about the useful-
ness (feasibility, acceptability and effectiveness) of internet-based
treatment interventions when offered in routine mental health care. In
order to “determine the place for E-health in our health care service
delivery systems” (Aardoom et al., 2016b) and to provide a reliable
basis for the implementation of E-health interventions in the health care
delivery system, we need to know whether Internet-based self-help in
outpatient settings is as effective as in the general population. Out-
patients (who have applied for face-to-face therapy) may respond dif-
ferently to online treatment, and their motivation to engage in an on-
line intervention may differ from that of other patients since they are
expecting to be provided with subsequent face-to-face treatment
anyway. We hope our study contributes to the limited body of knowl-
edge in this field.
The current study protocol describes the first randomized controlled
trial aiming to analyze the effects of an internet-based self-help inter-
vention for women with BN, BED and OSFED on a waiting list for face-
to-face outpatient treatment, conducted in an outpatient setting.
3.1.1. Strengths and challenges
A number of strengths and limitations of this study have to be taken
into consideration. Strengths involve the randomized controlled study
design and 12month follow-up to assess the short- and longer-term
effects of the intervention. The study intervention (everyBody Plus) has
been evaluated in many previous studies with different populations and
in different countries (Beintner et al., 2012) and proven to be effective
for women with subclinical eating disorders (Jacobi et al., 2012;
Saekow et al., 2015). A detailed statistical analysis plan has been set up
and state-of-the-art methods will be used to deal with missing data.
Also, a health-economic evaluation (cost-effectiveness) will be in-
cluded. Furthermore, this study will be conducted in outpatient routine
clinical practice under real life conditions using a pragmatic design.
Patients will be recruited from existing waiting lists and start their face-
to-face treatment whenever a time slot becomes available. The waiting
time will not be artificially extended. Thus, results will also shed light
on the feasibility of implementing online self-help to bridge waiting
time for outpatients. Finally, because the intervention is delivered on-
line, it is accessible 24/7 and can be accessed from any location al-
lowing for a lot of flexibility to accommodate the user.
However, the pragmatic design also bears some challenges: time
spent on the waiting list is variable, as is time spent in the online in-
tervention until the start of the face-to-face treatment. Since we do not
want to interfere with the routine processes in private practices or
outpatient treatment centers, we will have to take into account a
number of differences between cooperating recruitment partners and
enrolled participants.
Another challenge could be the attitude of some psychotherapists
regarding online interventions. Some may still be hesitant or reluctant
to utilize online interventions in general or as part of a stepped-care
approach of outpatient treatment delivery. Some psychotherapists be-
lieve that the psychological treatment cannot be adequately delivered
via the internet, because of concerns that a therapeutic alliance cannot
be established via such a ‘cold’ medium (Berger, 2016). Although there
is research evidence that an alliance similar to that in face-to-face set-
tings can be formed (Berger, 2016; Klasen et al., 2013), these concerns
remain persistent. As at least half of the participants in this trial are
recruited via cooperating psychotherapists (German site), this may pose
a challenge for the recruitment process of the study.
Finally, adherence represents a major challenge in internet inter-
ventions in general. Poor adherence may be associated with a negative
treatment outcome that can influence the patients' help-seeking beha-
vior in the future (Beintner et al., 2014). To maintain adherence, we
have therefore scheduled a number of e-mail reminders throughout this
trial. In addition, measurement of intervention adherence is a main goal
of all trials within the ICare project. A variety of adherence measures is
defined and will be analyzed in a separate ICare work package.
4. Conclusion
This trial will be conducted as part of the ICare (Integrating
Technology into Mental Health Care Delivery in Europe) project. The
aim of ICare researchers from six European countries is to improve
mental health care delivery in Europe and challenge traditional im-
plementation barriers.
We expect the findings of this study to contribute to the body of
knowledge on the effects, feasibility and acceptance of internet-based
interventions in outpatient settings, as part of a stepped-care approach
and to improve our knowledge on blending internet-based interventions
with conventional treatment. If successfully implemented as a part of
everyday routine, online interventions could be used to overcome the
enormous gap in the health care delivery system and disburden patients
and health care providers.
Trial status
Recruitment started in November 2016 and will continue through
31 May 2018 approximately. The first patient was enrolled in the study
on 29 November 2016. Follow-up assessments for the remaining pa-
tients are expected to be completed by May 2019.
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